These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39307765)

  • 1. [Pharmacovigilance guidelines for clinical application of Chinese patent medicines for external use].
    Cui X; Yang DQ; Xie ZN; Li YY; Wang ZF; Liu H; Liu FM; Zhao XX; Lu ZK; Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4285-4290. PubMed ID: 39307765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines].
    Wang LX; Yang S; Wei RL; Li YY; Cui X; Zhao XX; Peng WX; Liu FM; Wang MM; Li XH; Wang ZF; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4273-4278. PubMed ID: 39307763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacovigilance guidelines of Chinese patent medicines].
    Wang LX; Wang MM; Li YY; Wang ZF; Cui X; Zhao XX; Liu FM; Yang S; Wei RL; Wang YX; Zhang B; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4261-4265. PubMed ID: 39307761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacovigilance guidelines for clinical application of Chinese patent medicines for mucosal administration].
    Zhao XX; Hua H; Li YY; Wang ZF; Liu FM; Wei RL; Cui X; Yang S; Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4291-4297. PubMed ID: 39307766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for construction of traditional Chinese medicine pharmacovigilance system in medical institutions].
    Liu FM; Zhang L; Li YY; Wang ZF; Zhao XX; Cui X; Wei RL; Yang S; Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4266-4272. PubMed ID: 39307762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Technical specification for Instructions for Clinical Application of Chinese Patent Medicines in China Association of Chinese Medicine].
    Zhang XM; Sa RN; Zhang B; Zhang D; Lyu JT; Duan XJ; Lin ZJ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4563-4568. PubMed ID: 34581062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Scoping review of clinical evidence of Chinese patent medicines for digestive system diseases in children].
    Wu X; Dai ZQ; Xu SM; Li MM; Liao X
    Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4248-4255. PubMed ID: 36046915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interpretation of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
    Zhang XM; Lin ZJ; Zhang B; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):295-300. PubMed ID: 35178970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary study on general safe medication regularity of Chinese patent orthopedic medicines based on adverse reaction/event literature analysis].
    Wang YG; Shi XY; Jin R; Li HY; Kong XW; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1192-7. PubMed ID: 26226769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacovigilance guidelines for clinical application of traditional Chinese medicine injections].
    Fu CK; Liu H; Wang LX; Zou YH; Li MQ; Lin YM; Sun WH; Wei X; Hu YE; Xie YM; Li YY
    Zhongguo Zhong Yao Za Zhi; 2024 Aug; 49(16):4279-4284. PubMed ID: 39307764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for post-marketing research on clinical effectiveness of Chinese patent medicines].
    Wang ZF; Xie YM; Tang JY; Zhang JH; Sun X; Yang ZQ
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):842-848. PubMed ID: 38621888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Data-mining characteristics of adverse drug reactions and pharmacovi-gilance of Chinese patent drugs including Aconitum herbs].
    Zhang XM; Li F; Zhang B; Chen XF; Piao JZ
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):216-221. PubMed ID: 29552835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research on evaluation criteria over quality as core index of high grade Chinese patent medicine].
    Liu Y; Yu HC; Zhang J; Chen C; Cheng JT; Song ZH; Liu A
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4356-4360. PubMed ID: 30583641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of Chinese patent medicines for external-contraction febrile disease in Medical Records Integration of Palace in Qing Dynasty].
    Leung KP; Ji YK; Chen GS; Liu G
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5662-5669. PubMed ID: 36471984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Technical specifications for hospital-based intensive monitoring of post-marketing Chinese patent medicine].
    Xie YM; Liao X; Jiang JJ; Zhang YL; Ma R; Zhu MJ; Zhan SY; Liu JP; Liu J; Wen ZH; Yang ZQ; He Y; Li XL
    Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):2896-2901. PubMed ID: 31602831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Series of group standards of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions].
    Zhang B; Zhang XM; Lin ZJ; Sa RN; Lyu JT; Wu H; Li YL; Xu HZ; Huang ZK; Guo YB; Su XF; Duan XJ
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):285-294. PubMed ID: 35178969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction and practice on rational medication model of Chinese patent medicine for orthopedics based on ″symdrome-dosage-toxicity differentiation″ theory].
    Wang YG; Jin R; Qiang SS; Lin ZJ; Li HY; Lu S; Kong XW
    Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):350-353. PubMed ID: 28861985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present situation and prospect of quality standardization of Chinese patent medicines].
    Gao XM; Zhang JJ; Zhang DQ; Wang JX; Ou LN; Chen SH
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):868-72. PubMed ID: 17639993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enlightenment of international pharmacovigilance system on establishment of pharmacovigilance system of Chinese medicine].
    Cui X; Wang LX; Liu GY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5450-5455. PubMed ID: 34951195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre-searching during formulation of expert consensus on clinical application of Chinese patent medicines:Yanshen Jianwei Capsules as example].
    Feng X; Duan XJ; Sun JW; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(16):4287-4292. PubMed ID: 34467743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.